» Articles » PMID: 28914645

Notch Inhibitors and Their Role in the Treatment of Triple Negative Breast Cancer: Promises and Failures

Overview
Journal Curr Opin Oncol
Specialty Oncology
Date 2017 Sep 16
PMID 28914645
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Notch signaling is a highly evolutionarily conserved cell-to-cell communication system that is involved in a number of pivotal cellular processes, such as development, stem cell maintenance, cell fate specification, differentiation, proliferation, and death. Much progress has been made in understanding Notch signaling. This review will focus on the role of canonical Notch signaling pathway in breast cancer cause and progressing.

Recent Findings: In this review, we will discuss the results of the studies using drugs, which target the Notch pathway.

Summary: Notch sustains a proliferative signaling and protects from apoptosis, favors the angiogenic switch, the chemoresistance and radioresistance, controls the cancer stemness, and induces a prometastatic phenotype. Therefore, Notch-signaling represented an interesting target in the strategy against cancer growth.

Citing Articles

Structural basis of human γ-secretase inhibition by anticancer clinical compounds.

Guo X, Li H, Lu X, Liu H, U K, Yan C Nat Struct Mol Biol. 2024; .

PMID: 39653842 DOI: 10.1038/s41594-024-01439-8.


Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer.

Shen Q, Murakami K, Sotov V, Butler M, Ohashi P, Reedijk M Sci Adv. 2024; 10(44):eado8275.

PMID: 39475614 PMC: 11524187. DOI: 10.1126/sciadv.ado8275.


Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.

Hossain F, Ucar D, Monticone G, Ran Y, Majumder S, Larter K Front Immunol. 2023; 14:1244159.

PMID: 37901240 PMC: 10612326. DOI: 10.3389/fimmu.2023.1244159.


LINC00324 in cancer: Regulatory and therapeutic implications.

Xia Q, Shen J, Wang Q, Ke Y, Yan Q, Li H Front Oncol. 2023; 12:1039366.

PMID: 36620587 PMC: 9815511. DOI: 10.3389/fonc.2022.1039366.


Long Non-Coding RNA-Based Functional Prediction Reveals Novel Targets in Notch-Upregulated Ovarian Cancer.

Jeong S, Park S, Jo Y, Choi M, Lee G, Lee S Cancers (Basel). 2022; 14(6).

PMID: 35326706 PMC: 8946805. DOI: 10.3390/cancers14061557.